S 2875
Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Bill overview
This bill creates an exemption for certain drug manufacturers and wholesale distributors from needing a pharmacist license when they distribute dialysate drugs and devices used for home dialysis for patients with end-stage renal disease. To qualify, the drugs and devices must be FDA-approved, handled by a registered manufacturer or distributor, delivered in original packaging with a physician’s order, and subject to weekly quality assurance assessments by a consultant pharmacist. This aims to streamline the process of providing these essential medications to patients receiving home dialysis.
Sponsors
Official sponsors from legislative records.
Primary sponsors
Robert Singer
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.